France fines Sanofi for bad-mouthing generics

05/14/2013 | Bloomberg

France's antitrust regulator fined drugmaker Sanofi $52.8 million for casting doubt with doctors and pharmacists about the safety and efficacy of generic versions of the blood-thinner Plavix. Regulators say Sanofi urged doctors to require prescriptions for the branded drug be dispensed as written and tried to persuade pharmacists to use Sanofi's generic version instead of others.

View Full Article in:

Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA